Search clinical trials for: Bardoxolone methyl
Total 2983 results
-
Reata, a wholly owned subsidiary of BiogenCompleted
-
Reata, a wholly owned subsidiary of BiogenCompleted
-
Reata, a wholly owned subsidiary of BiogenWithdrawnDiabetes Mellitus, Type 2 | Renal Insufficiency, Chronic
-
Reata, a wholly owned subsidiary of BiogenCompletedHealthy | Hepatic ImpairmentUnited States
-
Reata, a wholly owned subsidiary of BiogenWithdrawnDiabetes Mellitus, Type 2 | Renal Insufficiency, Chronic
-
Reata, a wholly owned subsidiary of BiogenTerminatedDiabetes Mellitus, Type 2 | Renal Insufficiency, Chronic
-
Reata, a wholly owned subsidiary of BiogenTerminatedChronic Kidney Diseases | Autosomal Dominant Polycystic Kidney | Alport SyndromeUnited States, France, Australia, Japan, Spain, Puerto Rico
-
Reata, a wholly owned subsidiary of BiogenCompletedDiabetic NephropathyUnited States
-
Reata, a wholly owned subsidiary of BiogenCompletedDiabetes Mellitus, Type 2 | Renal Insufficiency, ChronicUnited States
-
NYU Langone HealthReata Pharmaceuticals, Inc.Completed
-
Reata, a wholly owned subsidiary of BiogenWithdrawn
-
Kyowa Kirin Co., Ltd.TerminatedDiabetic Kidney DiseaseJapan
-
Reata, a wholly owned subsidiary of BiogenTerminatedPulmonary HypertensionUnited States, Spain, Australia, United Kingdom, Canada, Belgium, Argentina, Israel, Japan, Philippines, Germany, Mexico, Brazil, Czechia, Netherlands
-
Reata, a wholly owned subsidiary of BiogenCompletedAdvanced Solid Tumors | Lymphoid MalignanciesUnited States
-
Kyowa Kirin Co., Ltd.Completed
-
Reata, a wholly owned subsidiary of BiogenCompletedDiabetic Nephropathy | Type 2 Diabetes | Chronic Kidney DiseaseUnited States
-
BiogenTerminatedType 2 Diabetes | Chronic Kidney Disease
-
Reata, a wholly owned subsidiary of BiogenTerminatedDiabetes Mellitus, Type 2 | Renal Insufficiency, Chronic
-
Reata, a wholly owned subsidiary of BiogenCompletedIdiopathic Pulmonary Fibrosis | Pulmonary Arterial Hypertension | Pulmonary Hypertension | Interstitial Lung Disease | Sarcoidosis | Idiopathic Interstitial Pneumonia | Cryptogenic Organizing Pneumonia | Desquamative Interstitial Pneumonia | Respiratory Bronchiolitis Associated Interstitial Lung Disease and other conditionsUnited States, Germany
-
Reata, a wholly owned subsidiary of BiogenCompletedAlport SyndromeUnited States, United Kingdom, Japan, Australia, France, Germany, Puerto Rico, Spain
-
Reata, a wholly owned subsidiary of BiogenTerminatedConnective Tissue Disease-Associated Pulmonary Arterial HypertensionUnited States, Spain, Japan, Australia, United Kingdom, Canada, Germany, Belgium, Argentina, Israel, Mexico, Brazil, Czechia, Netherlands, Philippines
-
Reata, a wholly owned subsidiary of BiogenTerminatedAutosomal Dominant Polycystic Kidney | ADPKDUnited States, Spain, United Kingdom, Australia, France, Japan, Germany, Belgium, Czechia, Italy
-
Reata, a wholly owned subsidiary of BiogenCompletedFocal Segmental Glomerulosclerosis | IgA Nephropathy | Autosomal Dominant Polycystic Kidney | CKD Associated With Type 1 DiabetesUnited States
-
PfizerTerminatedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1Japan
-
Reata, a wholly owned subsidiary of BiogenCompletedHealthy VolunteersUnited States
-
Reata, a wholly owned subsidiary of BiogenCompletedChronic Kidney DiseasesUnited States
-
Reata, a wholly owned subsidiary of BiogenTerminatedPancreatic Neoplasms | Pancreatic CancerUnited States
-
Stanford UniversityActive, not recruitingThyroid Cancer | Anaplastic Thyroid Cancer | Undifferentiated Thyroid CancerUnited States
-
Photolitec LLCNational Cancer Institute (NCI); Roswell Park Cancer InstituteRecruitingGlioblastoma Multiforme of Brain | Glioma, SarcomatousUnited States
-
Constellation PharmaceuticalsCompleted
-
The University of Texas Health Science Center at...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting
-
Constellation PharmaceuticalsCompletedAdvanced Solid TumorsUnited States
-
Promomed, LLCCompletedCOVID-19 | AstheniaRussian Federation
-
Reata, a wholly owned subsidiary of BiogenCompletedHealthy VolunteersUnited States
-
Crimson Biopharm Inc.Not yet recruiting
-
Peter MacCallum Cancer Centre, AustraliaMelbourne HealthCompleted
-
Assuta Hospital SystemsUnknownBasal Cell CarcinomaIsrael
-
EA Pharma Co., Ltd.Kissei Pharmaceutical Co., Ltd.CompletedA Study to Evaluate the Safety and Efficacy of AJM300 in Participants With Active Ulcerative ColitisColitis, UlcerativeJapan
-
Galderma R&DCompletedActinic KeratosesGermany
-
BiogenCompletedMultiple Sclerosis, Relapsing-RemittingPoland, Belgium, Turkey, Bulgaria, United States, Czechia, Germany, Kuwait, Latvia, Lebanon
-
University Hospital MuensterBiogenCompletedMultiple Sclerosis, Relapsing-RemittingGermany
-
ImmunoGen, Inc.GOG FoundationRecruitingOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States, Korea, Republic of, Spain, Australia, Canada, United Kingdom, Italy, Czechia, Philippines, Israel, Belgium
-
Vedic Lifesciences Pvt. Ltd.Completed
-
Promomed, LLCCompletedCOVID-19 | Asthenia | Cognitive Impairment | Functional MRIRussian Federation
-
Banner Life Sciences LLCCompletedMultiple SclerosisUnited States
-
Constellation PharmaceuticalsActive, not recruitingMetastatic Castration Resistant Prostate Cancer (mCRPC)United States
-
Cairo UniversityUnknownDenture, Complete
-
Galderma R&DNo longer availableBasal Cell Carcinoma | Bowen's Disease | Field Actinic Keratoses
-
Anthera PharmaceuticalsTerminatedRenal ImpairmentUnited States